Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Spectral Medical Inc
T.EDT
Alternate Symbol(s):
EDTXF
Healthcare
Biotechnology
Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theranostic company focused on advancing therapeutic solutions for sepsis and septic shock. The Company develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The Company also offers the Endotoxin Activity Assay (EAA), the diagnostic...
test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. It provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:EDT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(668)
•••
gebremeskel
X
Comment by
gebremeskel
on Nov 08, 2025 1:19pm
RE:RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
The news release and MD&A give the impression that the submission could have happened in October but that it made nore sense to put it off until the new year since (presumably because of the
...more
(289)
•••
BlueJays9293
X
Comment by
BlueJays9293
on Nov 07, 2025 10:30pm
RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
I completely agree with you Tech1, the biggest take-away from today is that Spectral has an insanely good working relationship with the FDA, almost symbiotic, I've never seen a Sponsor with this
...more
(616)
•••
TechOne
X
Comment by
TechOne
on Nov 07, 2025 8:34pm
RE:RE:RE:RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Most interesting thing for me was the comment that the company was in interactive discussions with FDA. Presumably, this should result in a better and more effective submission. So I guess we
...more
(289)
•••
BlueJays9293
X
Comment by
BlueJays9293
on Nov 07, 2025 7:09pm
RE:RE:RE:RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 10th would make zero sense because one way or the other it all comes down to the Govt reopening. That alone is the single most important factor in when the the final clinical module get
...more
(5)
•••
mrholty01
X
Comment by
mrholty01
on Nov 07, 2025 5:59pm
RE:RE:RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
This was the most interesting thing in this press release. Why is the conference call a month away. I read it first as November 10th which would be Monday but no its December 10th. This
...more
(289)
•••
BlueJays9293
X
Comment by
BlueJays9293
on Nov 07, 2025 5:00pm
RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Every shareholder should do their own interpretation of today's update, but the way I see it is that there are things in the first 3 non-clinical modules that needed to be brought up to current
...more
(71)
•••
Geery
X
Comment by
Geery
on Nov 07, 2025 4:54pm
RE:RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
If you feel that way, I expect you will bring it up on the upcoming Dec 10th call. I look forward to you posing that question and hearing their response. Geery
(181)
•••
Spamme54321
X
Comment by
Spamme54321
on Nov 07, 2025 4:20pm
RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Did they say if the goverment shut down is affecting them?
(350)
•••
hmmmmmmmm
X
Comment by
hmmmmmmmm
on Nov 07, 2025 3:00pm
RE:RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
If IR believed it would not delay the timing they would have stated it in writing in the release. They did not. They instead substituted the word "trajectory" as a piece of "linguistic
...more
(2)
•••
Rocket123
X
Post by
Rocket123
on Nov 07, 2025 1:38pm
Delay
I have been a long time shareholder of Spectral and it seems they always over promise and under deliver. Is management waiting to get more shares before they bring this purchase to conclusion?
...more
(668)
•••
gebremeskel
X
Comment by
gebremeskel
on Nov 07, 2025 9:29am
RE:RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
I have confirmed with IR that the deferral in timing is not expected to delay the current estimated date of FDA approval and commercialization launch.
(62)
•••
daviking
X
Comment by
daviking
on Nov 07, 2025 9:23am
RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Not surprised, even though the consultation aspect makes it sound positive. Over promised? Another 4-5 month wait. Sheesh!
(131)
•••
palinc2000
X
Comment by
palinc2000
on Nov 07, 2025 9:16am
RE:RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
This short deferral in timing is not expected to impact the overall commercialization trajectory and positions Spectral for a strong, high-quality submission. The deferral is a bit disappointing
...more
(7)
•••
RevJames
X
Comment by
RevJames
on Nov 07, 2025 8:04am
RE:New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Premarket Approval (“PMA”) submission, now targeted for Q1 2026 (previously Q4 2025)
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 07, 2025 7:30am
New Press Release - Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on Wednesday, December 10, 2025TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >